Aktienanalyse zu Adtalem Global Education Inc (ATGE)ATGEAdtalem Global Education Inc

Adtalem Global Education Inc. is a provider of healthcare education in the United States, preparing a diverse workforce with academic programs. Its healthcare programs include nursing, medicine, veterinary medicine, social and behavioral sciences and more. Its segments include Chamberlain, Walden, and Medical and Veterinary. Chamberlain segment offers degree and certificate programs in the nursing and health professions postsecondary education industry. Walden segment offers degree and certificate programs, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. Medical and Veterinary segment offers degree and certificate programs in the medical and veterinary postsecondary education industry. This segment includes American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It operates in the Academic & Educational Services sector (SERVICES-EDUCATIONAL SERVICES industry).

Adtalem Global Education Inc (ATGE) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows solid financial performance and positive analyst sentiment, the technical indicators suggest a bearish trend, and there are no strong trading signals or immediate positive catalysts to justify an entry point right now.

5 analysts cover ATGE: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 161.00.